|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08622 HUAKANG BIOMED
Nominal 
0.640 +0.050 (+8.475%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (3,061) | (48) | 1,286 | (2,378) | (3,924) |
| Net Cash from / (used in) Investing Activities | (4,425) | (1,153) | (6,109) | (2,055) | (1,936) |
| Net Cash from / (used in) Financing Activities | 6,297 | 1,023 | 2,324 | (1,366) | (1,107) |
| Increase / (Decrease) in Cash & Cash Equivalents | (1,189) | (178) | (2,499) | (5,799) | (6,967) |
| Cash & Cash Equivalents at beginning of period | 32,935 | 33,303 | 36,207 | 41,944 | 48,793 |
| Effect of Foreign Exchange Rate Changes | (251) | (190) | (405) | 62 | 118 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 31,495 | 32,935 | 33,303 | 36,207 | 41,944 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,369 |
| %Change | 33.165% |
| EPS / (LPS) | RMB -0.005 |
| NBV Per Share (¥) | RMB 0.104 |